The dietary supplement market in Japan is set to grow at a 6.2% CAGR through 2033. Key drivers include demand for mental wellness, gut health, and beauty supplements. Popular formats like gummies and ...
A2A Pharmaceuticals, Inc. ("A2A or "the company"), a clinical-stage pioneering biopharmaceutical company focused on developing innovative cancer therapies, today announced significant progress in its ...